Intraoperative Dexmedetomidine Infusion in Endovascular Intervention for Aneurysmal Subarachnoid Hemorrhage

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 6, 2024

Primary Completion Date

August 15, 2025

Study Completion Date

August 15, 2025

Conditions
DexmedetomidineInfusionEndovascularAneurysmal Subarachnoid Hemorrhage
Interventions
DRUG

Intraoperative Dexmedetomidine

Patients will be administered DEX 0.5 μg/kg for 10 min and then 0.4 μg/kg/h adjusted to 0.2-0.6 μg/kg/h.

OTHER

Placebo

Patients will receive normal saline.

Trial Locations (1)

31527

Tanta University Hospitals, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06352593 - Intraoperative Dexmedetomidine Infusion in Endovascular Intervention for Aneurysmal Subarachnoid Hemorrhage | Biotech Hunter | Biotech Hunter